HOME > Adverse reactions to virus removal therapy (2)   [ References ] K. Fujiwara, S. Kaneko, S. Kakumu, M. Sata, S. Hige, E. Tomita, S. Mochida, and The Virus Reduction Therapy Study Group. : Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load. Hepatology Research : 37:701-710, 2007 *Fibrinogen is a blood component associated with coagulation in the blood. If its level decreases, bleeding may occur.   Fibrinogen level is decreased by virus removal therapy. Whether virus removal therapy is performed should be judged on the basis of the fibrinogen level on the given day. HOME | What is hepatitis C virus? | If a person is infected with hepatitis C virus | Percentage of individuals infected with hepatitis C virus | What kinds of treatment are available? Criteria for evaluation of interferon therapy | What is virus removal therapy? | Method of treatment | Efficacy of treatment | Outline of treatment | Adverse reactions Health insurance coverage | Blood purification therapy for gastrointestinal disease Terms and Conditions | Privacy Policy Copyrights (C) 2008 Asahi Kasei Kuraray Medical Co.,Ltd. All Rights Reserved.